Surgical treatment of pancreatic adenocarcinoma: Actual survival and prognostic factors in 343 patients

European Journal of Cancer

Volumn 40, Issue 4, 2004, Pages 549-558

  Kuhlmann, K F D ^a   De Castro, S M M ^a   Wesseling, J G ^b   Ten Kate, F J W ^a   Offerhaus, G J A ^a   Busch, O R C ^a   Van Gulik, T M ^a   Obertop, H ^a   Gouma, D J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Adenocarcinoma; Biliary bypass; Gastric bypass; Palliative care; Pancreatic ductal adenocarcinoma; Pancreaticoduodenectomy; Prognostic factors; Surgery; Survival

Indexed keywords

ADULT; AGED; ARTICLE; BYPASS SURGERY; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; PALLIATIVE THERAPY; PANCREAS ADENOCARCINOMA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; TUMOR DIFFERENTIATION; TUMOR VOLUME;

EID: 1242293827     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2003.10.026     Document Type: Article

References (33)

1. Greenlee R.T., Murray T., Bolden S.et al. Cancer statistics, 2000. CA Cancer J. Clin. 50:2000;7-33.
2. Sener S.F., Fremgen A., Menck H.R.et al. Pancreatic cancer. a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database J. Am. Coll. Surg. 189:1999;1-7.
3. Tan H.P., Smith J., Garberoglio C.A. Pancreatic adenocarcinoma. an update J. Am. Coll. Surg. 183:1996;164-184.
4. Smith A.C., Dowsett J.F., Russell R.C.et al. Randomised rial of endoscopic stenting versus surgical bypass in malignant low bileduct obstruction. Lancet. 344:1994;1655-1660.
5. Lillemoe K.D., Cameron J.L., Hardacre J.M.et al. Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann. Surg. 230:1999;322-328.
6. Lillemoe K.D., Cameron J.L., Kaufman H.S.et al. Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial. Ann. Surg. 217:1993;447-455.
7. Geer R.J., Brennan M.F. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am. J. Surg. 165:1993;68-72.
8. Nitecki S.S., Sarr M.G., Colby T.V.et al. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann. Surg. 221:1995;59-66.
9. Sperti C., Pasquali C., Piccoli A.et al. Survival after resection for ductal adenocarcinoma of the pancreas. Br. J. Surg. 83:1996;625-631.
10. Wenger F.A., Peter F., Zieren J.et al. Prognosis factors in carcinoma of the head of the pancreas. Dig. Surg. 17:2000;29-35.
11. Ahmad N.A., Lewis J.D., Ginsberg G.G.et al. Long term survival after pancreatic resection for pancreatic adenocarcinoma. Am. J. Gastroenterol. 26:2001;2609-2615.
12. Lim J.E., Chien M.W., Earle C.C. Prognostic factors following curative resection for pancreatic adenocarcinoma. a population-based, linked database analysis of 396 patients Ann. Surg. 237:2003;74-85.
13. van Geenen R.C., van Gulik T.M., Offerhaus G.J.et al. Survival after pancreaticoduodenectomy for periampullary adenocarcinoma. an update Eur. J. Surg. Oncol. 27:2001;549-557.
14. Yeo C.J., Cameron J.L., Sohn T.A.et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s. pathology, complications, and outcomes Ann. Surg. 226:1997;248-257.
15. Allema J.H., Reinders M.E., van Gulik T.M.et al. Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region. Cancer. 75:1995;2069-2076.
16. Yeo C.J., Cameron J.L., Lillemoe K.D.et al. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann. Surg. 221:1995;721-731.
17. Kedra B., Popiela T., Sierzega M.et al. Prognostic factors of long-term survival after resective procedures for pancreatic cancer. Hepatogastroenterology. 48:2001;1762-1766.
18. Millikan K.W., Deziel D.J., Silverstein J.C.et al. Prognostic factors associated with resectable adenocarcinoma of the head of the pancreas. Am. Surg. 65:1999;618-623.
19. Sohn T.A., Yeo C.J., Cameron J.L.et al. Resected adenocarcinoma of the pancreas-616 patients. results, outcomes, and prognostic indicators J. Gastrointest. Surg. 4:2000;567-579.
20. Obertop H., Gouma D.J. Improved results for resection of periampullary adenocarcinoma. HPB Surg. 10:1996;125-128.
21. van Geenen R.C., ten Kate F.J., de Wit L.T.et al. Segmental resection and wedge excision of the portal or superior mesenteric vein during pancreatoduodenectomy. Surgery. 129:2001;158-163.
22. Gouma D.J., van Gulik T.M., de Wit L.T.et al. Complications after resection of biliopancreatic cancer. Ann. Oncol. 10(Supp. 4):1999;257-260.
23. Obertop H., Pedrazzoli S. Current views on surgical treatment of pancreatic cancer. Dig. Surg. 16:1999;263-264.
24. Gudjonsson B. Survival statistics gone awry. pancreatic cancer, a case in point J. Clin. Gastroenterol. 35:2002;180-184.
25. Engelken F.J., Bettschart V., Rahman M.Q.et al. Prognostic factors in the palliation of pancreatic cancer. Eur. J. Surg. Oncol. 29:2003;368-373.
26. Cameron J.L., Pitt H.A., Yeo C.J.et al. One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann. Surg. 217:1993;430-435.
27. Yeo C.J., Cameron J.L., Lillemoe K.D.et al. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann. Surg. 232:2000;419-429.
28. Halloran C.M., Ghaneh P., Bosonnet L.et al. Complications of pancreatic cancer resection. Dig. Surg. 19:2002;138-146.
29. van den Bosch R.P., van der Schelling G.P., Klinkenbijl J.H.M.P.G.et al. Guidelines for the application of surgery and endoprostheses in the palliation of obstructive jaundice in advanced cancer of the pancreas. Ann. Surg. 219:1994;18-24.
30. Nieveen van Dijkum E.J., Romijn M.G., Terwee C.B.et al. Laparoscopic staging and subsequent palliation in patients with peripancreatic carcinoma. Ann. Surg. 237:2003;66-73.
31. van Heek N.T., de Castro S.M.M., van Eijck C.H.et al. The need for a prophylactic gastrojejunostomy for unresectable periampullary cancer, a prospective randomized multi-center trial with special focus on assessment of quality of life. Ann. Surg. 238:2003;894-902.
32. Yeo C.J., Cameron J.L., Lillemoe K.D.et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2. randomized controlled trial evaluating survival, morbidity, and mortality Ann. Surg. 236:2002;355-366.
33. Pedrazzoli S., DiCarlo V., Dionigi R.et al. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas. a multicenter, prospective, randomized study. Lymphadenectomy Study Group Ann. Surg. 228:1998;508-517.